Tandem Diabetes Care TNDM Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 53.8%+1.7pp | 52.1%+2.9pp | 49.2%-2.4pp | 51.5%-2.0pp | |
| Operating margin | -18.5%-7.9pp | -10.5%+20.6pp | -31.2%-19.6pp | -11.6%-14.8pp | |
| Net margin | -20.2%-10.0pp | -10.2%+19.6pp | -29.8%-18.0pp | -11.8%-14.0pp | |
| Returns | |||||
| Return on equity | -97.9%-64.6pp | -33.3%+25.8pp | -59.1%-37.4pp | -21.7%-25.6pp | |
| Return on invested capital | -30.8%-16.4pp | -14.4%+29.0pp | -43.4%-20.2pp | -23.2%-29.6pp | |
| Efficiency | |||||
| Asset turnover | 1.1×+0.1× | 1×+0.2× | 0.7×-0.1× | 0.8×0.0× | |
| Liquidity | |||||
| Current ratio | 2.5×-0.4× | 2.9×-0.9× | 3.8×-1.3× | 5.1×-1.0× | |
| Leverage | |||||
| Debt-to-equity | 2.9×+0.9× | 2×+0.6× | 1.3×+1.0× | 0.3×+0.2× | |
| Per Share | |||||
| Book value per share | $2.28-42.6% | $3.98-17.1% | $4.80-29.8% | $6.83+4.0% | |
| Valuation | |||||
| Market capitalization | $1.03B-23.6% | $2.37B+22.6% | $1.93B-33.3% | $2.89B-69.8% | |
| Price / sales | 1×-0.4× | 2.5×-0.1× | 2.6×-1.0× | 3.6×-10.0× | |
| Price / book | 7.8×-0.9× | 9×+2.8× | 6.2×-0.4× | 6.6×-15.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Tandem Diabetes Care's profit margins?
- Tandem Diabetes Care (TNDM) runs a 54.9% gross margin and a -8.2% operating margin, with a -9.2% net margin.
- Where do Tandem Diabetes Care's ratios come from?
- Every ratio is computed from Tandem Diabetes Care's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
